In the inspections conducted into our sites and operations by medicinal authorities and our business partners, the investigators primarily check our compliance with the Good Practices (GxP) requirements, i.e. manufacturing (GMP), distribution (GDP), laboratory (GLP), clinical (GCP) and pharmacovigilance (GVP).